Skip to main content

Author: Customer Service

Virtualware appoints Jason Paltrowitz, Crossbridge Advisors founder, to International Advisory Board

Paltrowitz spent 12 years as Executive Vice President at OTC Markets Group and 11 at BNY Mellon’s Depositary Receipt Division. Bilbao, June 9, 2026.- Virtualware (Euronext Growth Paris: ALVIR), a leading European company in enterprise 3D software and immersive technologies, has appointed Jason Paltrowitz to its International Advisory Board. Paltrowitz, founder of New York-based Crossbridge Advisors LLC, will advise the company on U.S. market access and capital markets strategy. The move follows Virtualware’s listing on Euronext Growth Paris in June 2025 and points to a push to broaden access to U.S. and international investors. Paltrowitz served 12 years as Executive Vice President at OTC Markets Group and as Director of its London subsidiary, OTC Markets International. During his tenure, the firm added more than 5,000 issuers from 48...

Continue reading

KULR Technology Group Appoints New Chief Financial Officer and Independent Board Member

HOUSTON, June 09, 2026 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), an energy-systems platform company that enables the safe, certifiable deployment of ultra-high-power lithium battery systems for space and defense programs, mobility applications, hyperscale AI data centers, and telecom infrastructure applications, today announced the appointments of Dr. Michael Kimel as Chief Financial Officer and Mr. Steven Perez as a new independent Board member of the Company, each effective June 9, 2026. In connection with his appointment as Chief Financial Officer, Dr. Kimel resigned from the Company’s Board of Directors effective June 9, 2026. Dr. Kimel, an executive economist with more than 30 years of experience improving profitability, optimizing cost structures,...

Continue reading

Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium

Presentation to highlight fibrostenotic Crohn’s disease biology and the potential of a locally bioactivated PDE4 inhibitor prodrug approach Denver, CO, June 09, 2026 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today announced Mitchell Jones, MD, PhD, President and Chief Medical Officer, will present at the New York Academy of Sciences (“NYAS”) symposium, Molecular Pathways and Cellular Players in the Resolution of Organ Fibrosis, taking place on June 9, 2026, in New York, NY. The symposium brings together leading experts from academia, industry and clinical research to explore advances in fibrosis biology, emerging...

Continue reading

Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer

Discussion explores challenges of immunologically “cold” tumors and the potential for scalable engineered cell therapies to expand patient access in oncology Access the segment here CAMBRIDGE, Mass., June 09, 2026 (GLOBE NEWSWIRE) — Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the participation in a Virtual Investor KOL Connect segment featuring Ira S. Winer, MD, PhD, FACOG, Scientific Advisory Board Member at Ernexa Therapeutics, Professor in the Division of Gynecologic Oncology at Wayne State University School of Medicine and gynecologic oncologist at the Barbara Ann Karmanos Cancer Institute. During the discussion, Dr. Winer provided perspective on the significant unmet need that continues to exist in ovarian...

Continue reading

Duos Edge AI to Host Hereford Edge Data Center Open House

Event will bring together local and industry leaders to tour edge computing facility, which supports education and community technology growth HEREFORD, Texas, June 09, 2026 (GLOBE NEWSWIRE) — Duos Edge AI, Inc. (“Duos Edge AI”), a subsidiary of Duos Technologies Group, Inc. (Nasdaq: DUOT), is set to host an open house in Hereford, Texas on Thursday, June 18, 2026, from 9:00 AM to 11:00 AM CDT to showcase the company’s patented modular Edge Data Center (“EDC”), deployed in partnership with the Hereford Independent School District. Event DetailsDate: Thursday, June 18, 2026Time: 9:00 AM to 11:00 AM CDTLocation: Hereford Edge Data Center, 601 N 25 Mile Ave, Hereford, TX 79045RSVP: Reserve Your Spot During the open house, invited guests, partners, community leaders, education stakeholders, and industry representatives will discover...

Continue reading

VisionWave Brings AI-based Sensing Capabilities for the Defense and Security Sector by Acquiring a Controlling Interest in Foresight Autonomous

WEST HOLLYWOOD, Calif., June 09, 2026 (GLOBE NEWSWIRE) — VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave” or the “Company”), an advanced sensing technology company developing AI-driven, RF-based sensing and computational acceleration technologies for defense and commercial uses, today announced it has executed a definitive agreement with respect to the proposed strategic acquisition of controlling interest in Foresight Autonomous Holdings Ltd. (Nasdaq: FRSX). According to the Agreement, VisionWave will acquire up to 52% of Foresight’s outstanding shares in exchange for $17.5 million in VisionWave’s shares of common stock. The definitive agreement with Foresight will add important sensing technology to the Company’s STRATUM™ SENSE suite of sensing technologies, and follows the Company’s latest...

Continue reading

Flosum Outlines Agentic DevOps Approach as Enterprises Scale Salesforce Agentforce

Purpose-built Salesforce DevSecOps platform addresses the release management and governance demands of autonomous agent deployments ahead of World Tour London LONDON, UK, June 09, 2026 (GLOBE NEWSWIRE) — Flosum, the end-to-end enterprise DevSecOps platform purpose-built for Salesforce, today outlined its Agentic DevOps approach for enterprises deploying Salesforce Agentforce at scale. As global organizations move Agentforce from pilot to production, Flosum is working with enterprise customers to address the release management and governance demands that autonomous agent deployments introduce—demands that conventional DevOps workflows were not built to handle. Flosum will be present at Salesforce World Tour London on June 18 at ExCeL London, where the company will meet with enterprise architects, IT leaders, and Salesforce teams...

Continue reading

Academy Sports + Outdoors Reports First Quarter Fiscal 2026 Results

First Quarter Sales Growth of 6.7%; Comparable Sales Growth of 2.9%  eCommerce Sales Increase of 17.4% New Stores Comp Positive High Single Digits First Quarter Diluted GAAP EPS of $0.80; up 17.6%; Adjusted EPS of $0.93; up 22.4%  Opened Two New Stores in Ohio and Oklahoma Company Raises Guidance Based on First Quarter Performance KATY, Texas, June 09, 2026 (GLOBE NEWSWIRE) — Academy Sports and Outdoors, Inc. (Nasdaq: ASO) (“Academy” or the “Company”) today announced its financial results for the first quarter ended May 2, 2026. “We were pleased with the continued improvement in our results in Q1, with total sales up 6.7%, driven by increases in both traffic and average ticket,” said Steve Lawrence, Chief Executive Officer. “Based on our Q1 performance, we are raising the low end of our full-year guidance. While we expect inflationary...

Continue reading

ENvue Medical Launches AI Training Platform Establishing Artificial Intelligence Foundation for Robotic Feeding Tube Navigation

AI-based platform, ‘Ask Oscar™’, to accelerate adoption of ENvue’s Navigation Platform and enable clinicians to train independently and reduce implementation barriers  See Ask Oscar in action: https://envuemed.com/ask-oscar/#video TYLER, Texas, June 09, 2026 (GLOBE NEWSWIRE) — ENvue Medical (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today introduced ‘Ask Oscar™’, a new AI-powered training platform designed to address one of the biggest barriers to adoption of medical technology: training. The platform marks the Company’s transformation from a medical device maker into an AI platform company, with Ask Oscar as the first product to carry that vision. In addition to accelerating revenue in...

Continue reading

Worthington Enterprises Schedules Fiscal Fourth Quarter 2026 Earnings Call for June 24

COLUMBUS, Ohio, June 09, 2026 (GLOBE NEWSWIRE) — Worthington Enterprises Inc. (NYSE: WOR) will hold its quarterly earnings conference call Wednesday, June 24 at 8:30 a.m. ET. The company will discuss its fiscal fourth quarter results, which will be released after the market closes Tuesday, June 23. Please click here to register for the June 24 live audio webcast or visit IR.worthingtonenterprises.com. For those unable to listen live, a replay will be available in the Investors section of the company’s website approximately two hours after the completion of the call and will be archived for one year.   LIVE CONFERENCE CALL DETAILSDate:  Wednesday, June 24, 2026Webcast Link: https://events.q4inc.com/attendee/686020142Starting Time:  8:30 a.m. ETDomestic Participants: 833-461-5787Conference ID: 686020142   About...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.